6 Viruses That Can Cause Cancer – Cleveland Clinic

Note: This article is for educational purposes only and should not replace advice from a qualified healthcare professional. If you have concerns about infection, cancer risk, vaccination, screening or symptoms, talk with your doctor.

Can a Virus Really Cause Cancer?

When most people hear the word “virus,” they think of runny noses, stomach bugs, fever, coughs and the kind of miserable weekend that turns your couch into a medical recovery center. Cancer usually feels like a completely different subject. But in some cases, the two are connected.

To be very clear, cancer is not contagious like the flu. You cannot “catch cancer” by sitting next to someone, sharing an office or borrowing a pen from a coworker who forgot what personal space means. What can happen is more subtle: Certain viruses can infect specific cells, stay in the body for a long time, trigger chronic inflammation, weaken immune defenses or interfere with normal cell growth. Over many years, those changes may raise the risk of certain cancers.

The important word is may. Most people who get these viruses never develop cancer. Your immune system usually does an impressive job, even if it does not receive applause or vacation days. Still, medical experts pay close attention to these infections because many virus-related cancers are partly preventable through vaccination, safer sex, avoiding shared needles, screening, testing and treatment.

Inspired by the Cleveland Clinic discussion of cancer-linked viruses, this guide explains six viruses associated with cancer: Epstein-Barr virus, hepatitis B virus, hepatitis C virus, human herpesvirus 8, human immunodeficiency virus and human papillomavirus. We will look at how they spread, what cancers they are linked to and what practical steps can reduce risk.

How Viruses May Lead to Cancer

Viruses are tiny packages of genetic instructions. They cannot reproduce on their own, so they enter human cells and use cellular machinery to make copies of themselves. Most viral infections are short-lived. Your immune system notices the invasion, clears infected cells and files the whole episode under “annoying but handled.”

Cancer-linked viruses are different because they can sometimes persist. Some stay hidden in the body for life. Others cause long-term inflammation, especially in organs such as the liver. A few can interfere with the genetic controls that tell cells when to grow, repair themselves or stop dividing. When those controls fail, abnormal cells may begin multiplying in ways the body cannot manage.

Think of a healthy cell as a well-run kitchen. There are recipes, timers, safety rules and someone making sure the oven is not set to “volcano.” A cancer-linked virus may not burn the kitchen down immediately, but it can tamper with the recipe book, disable the timer or distract the safety inspector. Over time, mistakes can pile up.

Three major pathways explain much of the risk:

  • Genetic interference: Some viruses insert or influence genetic material inside cells, disrupting normal growth controls.
  • Chronic inflammation: Long-term infection can repeatedly damage tissue, forcing cells to repair and divide more often, which increases the chance of mutations.
  • Immune suppression: When the immune system is weakened, the body has a harder time controlling abnormal cells and other cancer-linked viruses.

The good news is that prevention is not mysterious. Vaccines, screening tests, antiviral medication and safer habits can dramatically reduce risk. Science may be complicated, but many of the prevention steps are refreshingly practical.

The 6 Viruses That Can Cause or Raise the Risk of Cancer

1. Epstein-Barr Virus (EBV)

Epstein-Barr virus is extremely common. Many people are infected at some point in life, often during childhood or adolescence. EBV is best known for causing infectious mononucleosis, commonly called “mono,” which is famous for fatigue, sore throat, swollen lymph nodes and making teenagers miss school for reasons that are finally medically approved.

EBV spreads mainly through saliva, which is why mono has long been nicknamed the “kissing disease.” But kissing is not the only route. Sharing cups, utensils, toothbrushes or food can also spread the virus. After infection, EBV usually stays in the body quietly for life.

Most people with EBV never develop cancer. However, EBV has been linked to certain lymphomas, including Burkitt lymphoma, Hodgkin lymphoma, some non-Hodgkin lymphomas and post-transplant lymphoproliferative disorders. It is also associated with nasopharyngeal carcinoma, a cancer that starts in the upper part of the throat behind the nose, and some stomach cancers.

There is no approved EBV vaccine. Prevention focuses on reducing exposure when someone is actively sick: avoid sharing drinks, utensils, lip balm and toothbrushes, and be cautious with close contact during mono-like illness. People with weakened immune systems, including some transplant recipients, may need closer medical monitoring because EBV-related complications are more likely when immune defenses are reduced.

2. Hepatitis B Virus (HBV)

Hepatitis B virus infects the liver. Some infections are short-term, but others become chronic, meaning the virus remains in the body for years. Chronic HBV infection can lead to liver inflammation, scarring, cirrhosis and eventually liver cancer, especially hepatocellular carcinoma, the most common form of primary liver cancer.

HBV spreads through infected blood and body fluids. Transmission can happen through sex, shared needles, accidental needle sticks, childbirth from an infected parent to a baby, and less commonly through shared personal items that may contain blood, such as razors or toothbrushes. It does not spread through casual contact, hugging, coughing or sharing a normal meal.

The strongest prevention tool is vaccination. The hepatitis B vaccine is routinely recommended for infants and is also recommended for many unvaccinated adults. This is one of the clearest examples of a vaccine that helps prevent cancer. Not “helps prevent a bad Tuesday,” not “helps prevent an inconvenient rash,” but helps reduce the risk of a serious cancer decades later.

People who already have chronic hepatitis B can still reduce risk. Antiviral treatment may lower the amount of virus in the body, reduce liver damage and decrease the chance of liver cancer. Regular medical follow-up is essential because liver disease can progress quietly. The liver is not known for dramatic announcements; it often suffers in silence until the problem becomes advanced.

3. Hepatitis C Virus (HCV)

Hepatitis C virus also targets the liver and can cause chronic infection. Over time, chronic HCV may lead to cirrhosis and liver cancer. HCV has also been associated with some non-Hodgkin lymphomas, though liver cancer is the major concern.

HCV spreads mainly through blood. Today, shared needles and injection equipment are major risk factors. Before widespread blood screening began in the United States, some people were infected through blood transfusions or organ transplants. Less commonly, HCV can spread through sex, childbirth or shared personal items contaminated with blood.

Unlike hepatitis B, there is no vaccine for hepatitis C. But there is excellent news: Modern direct-acting antiviral medications can cure most HCV infections. That is a big deal. Treating hepatitis C reduces liver inflammation, slows or prevents liver damage and lowers the risk of liver cancer, especially when treatment happens before severe cirrhosis develops.

Because many people with HCV have no symptoms for years, testing matters. Adults should ask their healthcare provider whether they should be screened, especially if they have ever used injection drugs, received blood products before modern screening, had abnormal liver tests or have other risk factors. Waiting for symptoms is not a winning strategy when a virus prefers stealth mode.

4. Human Herpesvirus 8 (HHV-8)

Human herpesvirus 8, also called Kaposi sarcoma-associated herpesvirus or KSHV, is linked most strongly to Kaposi sarcoma. Kaposi sarcoma can cause abnormal lesions in the skin, mouth, lymph nodes or internal organs. HHV-8 is also associated with rare lymphoproliferative disorders, including primary effusion lymphoma and multicentric Castleman disease.

HHV-8 is not as common in the general U.S. population as some other viruses on this list. It can spread through saliva, sexual contact and blood. For many people, infection causes no obvious symptoms. The risk of HHV-8-related cancer rises when the immune system is weakened, especially in people with untreated HIV or those taking strong immune-suppressing medications after organ transplantation.

There is no vaccine for HHV-8. Risk reduction focuses on safer sex, avoiding exposure to infected blood and protecting immune health. For people living with HIV, consistent antiretroviral therapy greatly reduces the risk of Kaposi sarcoma by helping the immune system recover and stay stronger.

HHV-8 is a reminder that cancer risk is rarely about one factor acting alone. The virus matters, but immune function matters too. A healthy immune system is like a nightclub bouncer with a clipboard. When it is working well, suspicious characters have a much harder time sneaking into the VIP area.

5. Human Immunodeficiency Virus (HIV)

HIV is different from several other viruses on this list because it does not usually cause cancer by directly turning normal cells into cancer cells. Instead, HIV weakens the immune system. When immune defenses are low, the body has more trouble controlling cancer-linked infections such as HPV, EBV and HHV-8. It also has a harder time finding and destroying abnormal cells early.

HIV spreads through blood, semen, vaginal fluids, rectal fluids and breast milk. It can be transmitted through sex, shared needles, childbirth, breastfeeding and certain blood exposures. It does not spread through hugging, handshakes, toilet seats, mosquitoes or sharing a pizza. The pizza may cause arguments over toppings, but not HIV.

Cancers associated with HIV include Kaposi sarcoma, non-Hodgkin lymphoma and cervical cancer. People with HIV may also have higher risk of anal cancer, Hodgkin lymphoma, liver cancer, lung cancer and some head and neck cancers. The level of risk depends on immune health, viral control, co-infections, smoking and access to screening and treatment.

Prevention and treatment have improved dramatically. Condoms, sterile needles, HIV testing, pre-exposure prophylaxis for people at risk and prompt treatment after diagnosis all help. Antiretroviral therapy can reduce HIV to undetectable levels in the blood, protect immune function and lower the risk of HIV-related complications, including some cancers.

6. Human Papillomavirus (HPV)

Human papillomavirus is one of the most important cancer-linked viruses because it is common and because prevention works. HPV includes many virus types. Some cause common warts or genital warts. Others are considered high-risk because persistent infection can lead to cancer.

HPV spreads through intimate skin-to-skin contact, including vaginal, anal and oral sex. Most sexually active people are exposed at some point. In most cases, the immune system clears the infection without symptoms. Problems arise when high-risk HPV types persist for years and cause cell changes that become precancerous and, if not found and treated, cancerous.

HPV can cause cervical cancer, anal cancer, oropharyngeal cancer, penile cancer, vaginal cancer and vulvar cancer. Oropharyngeal cancers affect the back of the throat, including the base of the tongue and tonsils. This surprises many people because HPV is often discussed only in connection with cervical cancer, but its cancer footprint is wider.

The HPV vaccine is a major cancer-prevention tool. It works best when given before exposure to HPV, which is why vaccination is commonly recommended starting in early adolescence. Some adults may also benefit and should discuss eligibility with a healthcare provider. Cervical cancer screening with HPV testing and/or Pap testing remains important because screening can find abnormal cell changes before cancer develops.

Quick Comparison: Virus, Cancer Link and Prevention

Virus Main Cancer Links Key Prevention Steps
EBV Lymphomas, nasopharyngeal cancer, some stomach cancers Avoid sharing saliva-related items during illness; monitor high-risk immune conditions
HBV Liver cancer Hepatitis B vaccination, testing, safer sex, sterile needles, antiviral care
HCV Liver cancer, some lymphomas Testing, curative antiviral treatment, avoiding blood exposure
HHV-8 Kaposi sarcoma, rare lymphomas Safer sex, avoiding blood exposure, strong HIV control when applicable
HIV Kaposi sarcoma, lymphomas, cervical, anal and other cancers Testing, condoms, PrEP when appropriate, sterile needles, antiretroviral therapy
HPV Cervical, anal, throat, penile, vaginal and vulvar cancers HPV vaccination, cervical screening, safer sex

Who Should Talk to a Doctor About Testing?

You do not need to panic about every virus you have ever had. That would be exhausting, and frankly, your search history has suffered enough. But some situations deserve a conversation with a healthcare provider.

Ask about hepatitis B and hepatitis C testing if you have risk factors such as a history of injection drug use, possible blood exposure, abnormal liver tests, a partner with viral hepatitis, birth in a region where hepatitis B is more common or a history of transfusion before modern screening practices. Pregnant people are commonly screened for hepatitis B because treatment and newborn vaccination can prevent transmission to the baby.

Ask about HIV testing if you have had unprotected sex, shared needles, had a partner with HIV or simply do not know your status. Knowing your status is not a judgment; it is information. And information is much easier to treat than denial wearing sunglasses.

For HPV, follow cervical cancer screening guidelines if you have a cervix. Screening can detect high-risk HPV infection and abnormal cells before cancer develops. People with a history of HIV, immune suppression or prior HPV-related disease may need more individualized screening plans.

Prevention: The Practical Playbook

Get Vaccinated When Eligible

Two vaccines are especially important in virus-related cancer prevention: the HPV vaccine and the hepatitis B vaccine. These vaccines do not treat existing cancer, but they help prevent infections that can lead to cancer later. That is prevention doing its job quietly in the background, like a good password manager but for your immune system.

Use Screening as Early Warning

Cervical cancer screening can identify HPV-related cell changes before they become cancer. Hepatitis testing can identify infections before severe liver damage develops. HIV testing can lead to early treatment that protects immune function. Screening is not about expecting bad news; it is about catching fixable problems while they are still small.

Avoid Blood Exposure

Never share needles or injection equipment. Avoid sharing razors or toothbrushes that may have blood on them. Make sure tattoos and piercings are done with sterile equipment by licensed professionals. Tiny blood exposures can matter when viruses such as HBV, HCV and HIV are involved.

Practice Safer Sex

Condoms and dental dams reduce the risk of several sexually transmitted infections, including HIV, hepatitis B and HPV. They do not eliminate all HPV risk because HPV can spread through skin-to-skin contact in areas not covered by a condom, but they still reduce risk. Open communication with partners and regular testing also help.

Treat Chronic Infections

Modern medicine has powerful tools. Hepatitis C can often be cured. Hepatitis B can often be controlled. HIV can be managed with antiretroviral therapy. Treating chronic viral infections helps protect the organs and immune system that cancer-linked viruses may otherwise exploit.

Common Myths About Viruses and Cancer

Myth 1: If a virus is linked to cancer, everyone who gets it will develop cancer.

False. Most people with EBV, HPV or other cancer-linked viruses never develop cancer. Cancer usually requires multiple steps, often over many years, and is influenced by immune health, genetics, lifestyle, co-infections and access to preventive care.

Myth 2: Cancer itself is contagious.

False. Cancer does not spread from person to person like a cold. Some infections that increase cancer risk can spread, but the cancer itself is not something you catch through ordinary contact.

Myth 3: Vaccines are only about preventing infections, not cancer.

False. The HPV vaccine and hepatitis B vaccine are also cancer-prevention tools. They reduce the risk of infections that can lead to cancer years later.

Myth 4: No symptoms means no problem.

False. Hepatitis B, hepatitis C, HIV and HPV can be silent for long periods. Testing and screening matter precisely because some infections do not wave a red flag early.

Experiences and Real-Life Lessons Related to Cancer-Causing Viruses

One of the most common real-world experiences around virus-related cancer risk is surprise. Many people learn about HPV only in the context of cervical cancer screening, then later discover it can also be linked to throat, anal, penile, vaginal and vulvar cancers. That “wait, it can do what?” moment is understandable. Public health messaging has often focused on one cancer at a time, while viruses are annoyingly uninterested in our neat categories.

Parents often experience a different kind of hesitation when the HPV vaccine comes up. Because HPV is sexually transmitted, some families feel awkward discussing vaccination for preteens. But the medical logic is simple: Vaccines work best before exposure. It is the same reason people put on a seat belt before the car moves, not halfway through a dramatic left turn. Framing the HPV vaccine as cancer prevention, rather than as a conversation about future sexual activity, often makes the decision clearer and less uncomfortable.

Adults who receive a hepatitis B or hepatitis C diagnosis often describe feeling confused because they may not feel sick. This can be frustrating. If nothing hurts, why worry? The answer is that the liver can tolerate damage quietly for years. Chronic viral hepatitis may progress slowly, and by the time symptoms appear, scarring or cirrhosis may already be advanced. That is why testing is so valuable. It turns a hidden problem into a manageable one.

Another common experience is fear after a positive test result. A positive HPV test, hepatitis test or HIV test can sound terrifying, especially when someone immediately searches online and lands in the internet’s haunted basement. But a positive test is not a cancer diagnosis. It is a signal to take the next step: follow-up testing, monitoring, treatment or screening. Many infections can be controlled, cured or watched carefully. The worst plan is usually pretending the result never happened.

People living with HIV have also seen enormous changes over the past few decades. With effective treatment, many can keep the virus controlled, maintain immune function and live long lives. Cancer prevention in HIV care includes antiretroviral therapy, HPV vaccination when appropriate, cervical and anal cancer screening for certain groups, hepatitis testing, smoking cessation and regular medical visits. In other words, HIV care is no longer only about controlling one virus; it is about protecting the whole body over time.

There is also a lesson for anyone who thinks prevention is boring. Prevention rarely has dramatic music. No one throws confetti when a vaccine prevents a cancer that never appears 25 years later. Screening appointments do not feel heroic. Taking antiviral medication may feel routine. But these quiet actions can change the future. They are the health equivalent of fixing a roof before the storm instead of placing buckets around the living room afterward.

The most practical takeaway from these experiences is that people do better when they replace shame with information. Viruses are common. Infection is not a moral failure. Testing is responsible. Vaccination is protective. Treatment is powerful. And asking questions early is much easier than dealing with complications late.

Conclusion

Viruses are not the cause of most cancers, but a small group of persistent infections can raise cancer risk in important ways. Epstein-Barr virus, hepatitis B, hepatitis C, human herpesvirus 8, HIV and HPV are all linked to specific cancers through different mechanisms, including chronic inflammation, immune suppression and changes in cell growth.

The hopeful part is that virus-related cancer risk is often manageable. HPV and hepatitis B vaccines can prevent major cancer-linked infections. Hepatitis C can often be cured. HIV can be controlled with treatment. Cervical screening can catch HPV-related cell changes early. Safer sex, sterile needles and routine testing can reduce risk across several infections.

In short, cancer prevention is not only about avoiding tobacco, eating vegetables and trying to convince yourself that stairs count as a workout. It also includes understanding infections, using vaccines, getting screened and treating chronic viruses before they cause long-term harm. Tiny viruses can be troublemakers, but modern prevention gives us a very solid playbook.